For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms ...
The researchers found an unknown interaction in the brain and was able to target it.
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...
Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...
Parkinson's disease is degenerative neurological disorder that primarily affects movement due to damage to dopamine-producing nerve cells ...
Avion Pharmaceuticals, an Alora Pharmaceuticals subsidiary company focused on advancing treatment for Parkinson's disease, is proud to announce the findings from a recently published study examining ...
The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.
FDA fast-tracks novel Parkinson’s cell therapy NouvNeu001, advancing treatment for dopaminergic neuron loss and motor ...
A few years ago, the organizers of one of the largest U.S. exercise programs for people with Parkinson's disease realized they had a problem: Most of the students were white. "We're always asking ...
On Tuesday, January 13, members of the Nuvance Health team visited Newtown Senior Center to talk about Parkinson’s disease ...